Document Detail


Protecting the heart: Biological targets and Clinical Strategies.
MedLine Citation:
PMID:  23270555     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
The pathophysiology of myocardial damage in the setting of ischemic cardiomyopathy is complicated by the fact that the process of restoring blood flow to the ischemic cardiomyocytes can itself induce injury to the myocardium. This phenomenon, termed reperfusion injury, reduces the benefits of vessel recanalization and contributes to the damage initiated by occlusion. The interest on techniques aiming at protecting the heart from ischemia-reperfusion (IR) injury has constantly grown over the last two decades. Three main actors of IR injury can be identified: 1) cardiomyocite-related damage, 2) vascular-related injury and 3) inflammatory-related injury. Ideally targeting the series of molecular events that take place during myocardial reperfusion, this area of research focuses on the different strategies that may help to render the heart more resistant to the ischemic insult. The aim of this article is to highlight the clinical relevance of IR injury, how IR-injury can be assessed clinically as well as to review the current strategies, both pharmacological and non pharmacological, that show promise for translation to clinical practice.
Authors:
Alberto R De Caterina; Florim Cuculi; Adrian P Banning; Rajesh K Kharbanda
Related Documents :
10197665 - Transmyocardial laser revascularization: early results and 1-year follow-up.
24482385 - Adipocytokine resistin correlates with oxidative stress and myocardial injury in patien...
19049775 - Vineberg operation: a successful case 35 years later.
12007735 - Vegf gene delivery for treatment of ischemic cardiovascular disease.
3996245 - Amiodarone treatment in patients with ventricular arrhythmias.
24775385 - Innovations in heart rhythm disturbances: cardiac electrophysiology, arrhythmias, and c...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-21
Journal Detail:
Title:  Current pharmaceutical design     Volume:  -     ISSN:  1873-4286     ISO Abbreviation:  Curr. Pharm. Des.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Oxford University Hospitals Headley Way, Oxford OX3 9DU, United Kingdom. Rajesh.Kharbanda@orh.nhs.uk.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Cardioprotection techniques: preconditioning, postconditioning and remote conditioning (basic scienc...
Next Document:  Modulation of individual susceptibility to the no-reflow phenomenon after acute myocardial infarctio...